Author:
Cathomas Richard,Hartmann Michael
Publisher
Springer Berlin Heidelberg
Reference31 articles.
1. Abouassaly R, Fosså SD, Giwercman A, Kollmannsberger C, Motzer RJ, Schmoll HJ, Sternberg CN (2011) Sequelae of treatment in long-term survivors of testis cancer. Eur Urol 60:516–526
2. Albers P, Siener R, Krege S et al (2008) Randomized phase III trial comparing tetroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapie in the adjuvant treatment of stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group. J Clin Oncol 26(18):2966–2972
3. Bandak M, Jørgensen N, Juul A et al (2016) Testosterone deficiency in testicular cancer survivors – a systematic review and meta-analysis. Andrology 4:382–388
4. Beyer J, Albers P, Altena R et al (2013) Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ- cell cancer. Ann Oncol 24(4):878–888
5. Cathomas R, Hartmann M, Krege S, Souchon R, Lorch A, Mayer F, De Santis M, Gillessen S (2011) Interdisciplinary evidence-based recommendations for the follow-up of testicular germ cell cancer patients. Onkologie 34:59–64